A method for preparing niprazinzine

The synthesis of niprazimine was simplified by using an amide coupling-methanesulfonation-nucleophilic substitution process, which solved the problems of harsh reaction conditions and safety risks in the existing technology, and achieved the preparation of niprazimine with high yield and high purity.

CN123106526APending Publication Date: 2026-11-17SUZHOU RUIFENG PHARM R & D CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611359797.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-03
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing synthetic routes for niprazimine involve harsh reaction conditions, cumbersome post-processing, and safety risks, affecting yield and purity and making large-scale production difficult.

Method used

The process route of amide coupling-methanesulfonation-nucleophilic substitution was adopted, using nicotinic acid, 3-amino-1-butanol, triethylamine, HATU, methanesulfonyl chloride and 1-(4-fluorophenyl)piperazine as raw materials, and purified by dichloromethane solvent and silica gel column chromatography, simplifying the post-processing steps.

Benefits of technology

It reduces the safety risks of reaction operations, improves the convenience and safety of process operations, enhances product yield and purity, and is suitable for large-scale preparation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106526A_ABST
    Figure CN123106526A_ABST
Patent Text Reader

Abstract

This invention relates to the field of pharmaceutical synthesis technology, specifically to a method for preparing niprazine, comprising the following steps: using nicotinic acid and 3-amino-1-butanol as reactants, triethylamine as an acid-binding agent, and HATU as a coupling agent, an amide coupling reaction is carried out in an organic solvent to obtain... N -(4-hydroxybut-2-yl)nicotinamide, N 3-(nicotinamide)-2-hydroxybutyridine (Nicotinamide) is dissolved in dichloromethane and reacted with methanesulfonyl chloride under alkaline conditions to undergo methanesulfonation to obtain 3-(nicotinamide)-butylmethanesulfonate. This 3-butylmethanesulfonate is then dissolved in dichloromethane and reacted with a dichloromethane solution of 1-(4-fluorophenyl)piperazine under alkaline conditions to undergo nucleophilic substitution to obtain nipraazine. The method provided by this invention uses mild reaction conditions in each step, effectively avoiding the problems of difficult production operations and lower safety caused by harsh reaction conditions in existing technologies, thus improving the convenience and safety of the process operation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of drug synthesis technology, specifically to a method for preparing niprazimine. Background Technology

[0002] Niprazine is a histamine H1 receptor antagonist with potent sedative effects. It can act on biological targets related to the central nervous system, have a certain impact on neurotransmitter-related signaling pathways, and exhibit certain pharmacological activities in the central nervous system. Therefore, it has certain research value in the study of drugs and active compounds related to the nervous system.

[0003] Currently, there are few reports on the synthesis methods of niprazimine. The relevant synthetic routes that can be obtained after searching are as follows: ; The above method mainly includes four steps: the first step is to construct the corresponding intermediate via the Mannich reaction; the second step is to carry out a condensation reaction using hydroxylamine hydrochloride; the third step is to reduce it using lithium aluminum hydride; and the fourth step is to form an amide using nicotinyl chloride, ultimately yielding niprazinzine. This synthetic route involves numerous reaction steps, and some reactions have high requirements for reaction conditions and operation. The post-processing is also quite cumbersome, increasing the amount of organic solvents used and energy consumption. Furthermore, the multi-step reaction and separation / purification processes can easily lead to the loss of intermediates or products, thus affecting the yield and purity of the final product. Some of the reagents used in the reactions have high reactivity, requiring strict control over reaction conditions and operational safety, increasing safety risks during production and hindering the scale-up and large-scale implementation of the process.

[0004] Therefore, it is of great significance to develop a method for preparing niprazinzine with mild reaction conditions, safe operation, simple post-processing, and high yield and purity, so as to improve the safety, stability and ease of operation of the preparation process. Summary of the Invention

[0005] The purpose of this invention is to provide a method for preparing niprazimine, in order to solve the problems mentioned in the background art, such as harsh reaction conditions, cumbersome post-processing, and safety risks in the current synthetic route of niprazimine.

[0006] The technical solution of the present invention to solve the above-mentioned technical problems is as follows: A method for preparing niprazine includes the following steps: (1) Using nicotinic acid and 3-amino-1-butanol as reactants, triethylamine as an acid-binding agent and HATU as a coupling agent, an amide coupling reaction was carried out in an organic solvent to prepare compound 2; (2) Compound 2 was dissolved in dichloromethane, and methanesulfonyl chloride and triethylamine were added to carry out methanesulfonation reaction to obtain compound 3; (3) Dissolve compound 3 in dichloromethane, add a dichloromethane solution of 1-(4-fluorophenyl)piperazine and triethylamine, and carry out a nucleophilic substitution reaction to obtain the niprazine; The compound 2 is N -(4-hydroxybutyl-2-yl)nicotinamide; Compound 3 is 3-(nicotinamide)butyl methanesulfonate; The process route is as follows: .

[0007] Furthermore, in step (1), the molar ratio of nicotinic acid, 3-amino-1-butanol, HATU and triethylamine is 1:1:1.20:2.

[0008] Furthermore, in step (2), the molar ratio of compound 2, methanesulfonyl chloride, and triethylamine is 1:1.05:1.2.

[0009] Furthermore, the molar ratio of compound 3, 1-(4-fluorophenyl)piperazine, and triethylamine is 1:1.05:1.2.

[0010] Furthermore, the organic solvent is dichloromethane.

[0011] Furthermore, the temperature for the amide coupling reaction is 20-25℃, and the reaction time is 16h.

[0012] Further, after the reaction in step (1) is completed, the reaction solution is washed with water and hydrochloric acid solution in sequence. The resulting organic phase is dried, filtered and concentrated to obtain crude compound 2, which is then purified by silica gel column chromatography to obtain compound 2. The silica gel column chromatography eluent is a mixed solution of methanol and dichloromethane.

[0013] Further, the specific steps of step (2) are as follows: triethylamine is added to the dichloromethane solution of compound 2, methanesulfonyl chloride is added dropwise under ice bath conditions, the temperature is raised to room temperature after the addition is completed, the reaction is carried out for 2.5 h, water is added to quench the reaction after the reaction is completed, the organic phase is washed, dried, filtered and concentrated to obtain the crude product of compound 3, and compound 3 is purified by silica gel column chromatography; the eluent for silica gel column chromatography is a mixed solution of ethyl acetate and cyclohexane.

[0014] Further, the specific steps of step (3) are as follows: triethylamine is added to the dichloromethane solution of compound 3, and a dichloromethane solution of 1-(4-fluorophenyl)piperazine is added dropwise under ice bath conditions. After the addition is completed, the temperature is raised to room temperature and refluxed for 4.5 h. After the reaction is completed, water is added to quench the reaction. The organic phase is washed, dried, filtered and concentrated to obtain crude niprazine, which is then purified by silica gel column chromatography to obtain niprazine. The eluent for silica gel column chromatography is a mixed solution of ethyl acetate and cyclohexane.

[0015] The beneficial effects of this invention are as follows: This invention provides a method for preparing niprazinzine, which uses an amide coupling-methanesulfonation-nucleophilic substitution process to prepare niprazinzine. The raw materials and reagents used are readily available, the reaction conditions in each step are mild, and the reaction process does not require strict anhydrous and oxygen-free operation, which reduces the requirements for reaction equipment and operating environment. It effectively avoids the problems of difficult production operation and low safety caused by harsh reaction conditions in the prior art, thereby improving the convenience and safety of process operation.

[0016] The post-processing of this invention is mainly completed through conventional extraction, washing, drying and column chromatography. The process is simple, easy to operate and has good controllability. It can effectively solve the problems of cumbersome post-processing steps and complicated operation in the prior art and reduce production and operation costs.

[0017] The reactions in each step of this invention exhibit good reaction selectivity and high reaction yield, which can reduce the generation of side reactions and impurities, and is beneficial for obtaining niprazine products with high purity. The preparation method is easy to control and has good adaptability to process scale-up, making it suitable for the large-scale preparation of niprazine. Attached Figure Description

[0018] Figure 1 This invention relates to a method for synthesizing niprazimine; Figure 2 Niprazine of the present invention 1 H NMR spectrum. Detailed Implementation

[0019] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0020] See attached document Figure 1 and 2 This invention provides a method for preparing niprazine.

[0021] Example 1 (1) A solution of nicotinic acid (17.48 g, 142 mmol) and triethylamine (25.09 g, 284 mmol) in dichloromethane (100 mL) was added to a reaction flask, followed by the addition of HATU (64.81 g, 170 mmol) and 3-amino-1-butanol (12.68 g, 142 mmol). The mixture was stirred at room temperature for 16 h. Thin-layer chromatography (TLC) was used to detect the complete reaction of the reactants, with CHCl3 / MeOH = 95:5 as the developing solvent. After the reaction was complete, the reaction solution was washed successively with water and 2M hydrochloric acid, shaken thoroughly, and allowed to stand for separation. The organic phase was collected, dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure to remove the solvent, yielding the crude product of compound 2. The crude product was purified by silica gel column chromatography using methanol and dichloromethane as eluents (methanol and dichloromethane volume ratio of 4:96). The target product fraction was collected, concentrated, and the solvent was removed to obtain oily compound 2 (22.62 g, yield 82%).

[0022] (2) Triethylamine (12.12 g, 120 mmol) was added to a solution of compound 2 (19.4 g, 100 mmol) in dichloromethane (120 ml). Then, methanesulfonyl chloride (12.03 g, 105 mmol) was added dropwise under ice bath conditions. After the addition was complete, the mixture was allowed to naturally warm to room temperature and reacted for 2.5 h. The reaction was confirmed by TLC (CHCl3 / MeOH = 95:5) after the starting material reaction was complete. The mixture was then quenched with water, and the organic phase was separated. The organic phase was washed with saturated sodium bicarbonate, dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure to remove the solvent, yielding crude compound 3. The crude compound was purified by silica gel column chromatography using ethyl acetate and cyclohexane as eluents (ethyl acetate to cyclohexane volume ratio 10:90). The target product fraction was collected, concentrated, and the solvent removed to obtain compound 3 (25.32 g, yield 93%).

[0023] (3) Triethylamine (6.01 g, 60 mmol) was added to a solution of compound 3 (13.61 g, 50 mmol) in dichloromethane (100 mL). Under ice bath conditions, a solution of 1-(4-fluorophenyl)piperazine (9.46 g, 52.5 mmol) in dichloromethane (20 mL) was added dropwise. After the addition was complete, the temperature was raised to room temperature and refluxed for 4.5 h. After the reaction of the starting materials was complete, it was detected by TLC (CHCl3 / MeOH = 95:5). The reaction was quenched with water and the organic phase was separated. The organic phase was washed with saturated sodium bicarbonate, dried with anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure to remove the solvent, yielding crude compound 1 (niprazine). The crude compound 1 was purified by silica gel column chromatography using an ethyl acetate / cyclohexane system as the eluent for gradient elution. The volume ratio of ethyl acetate to cyclohexane in the elution system was gradually adjusted from 15:85 to 30:70. The target product fraction was collected, concentrated, and the solvent was removed to obtain niprazimine (17.82 g, yield 76%).

[0024] According to the proton spectrum of niprazine ( Figure 1 Specifically, niprazimine was purified by silica gel column chromatography with gradient elution (ethyl acetate:cyclohexane = (15:85)-(30:70), v / v). 1 H-NMR (400MHz, DMSO-) d 6) δ 9.02 (s,1H), 8.71-8.70 (m, 1H), 8.47(d, 1H, J =8.0Hz), 8.21-8.19 (m, 1H), 7.49-7.52(dd, 1H, J =4.8Hz, 8.0Hz), 7.02-7.07 (m, 2H), 6.92-6.96 (m, 2H), 4.04-4.14 (m,1H), 3.07 (s, 4H), 2.52 (s, 4H), 2.41 (s, 2H), 1.68-1.81 (m, 2H), 1.21-1.19(d, 3H, J =6.4Hz).

[0025] Although embodiments of the invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit of the invention, the scope of which is defined by the appended claims and their equivalents.

Claims

1. A process for the preparation of nipradilol, characterized by, Includes the following steps: (1) Using nicotinic acid and 3-amino-1-butanol as reactants, triethylamine as an acid-binding agent and HATU as a coupling agent, an amide coupling reaction was carried out in an organic solvent to prepare compound 2; (2) Compound 2 was dissolved in dichloromethane, and methanesulfonyl chloride and triethylamine were added to carry out methanesulfonation reaction to obtain compound 3; (3) Dissolve compound 3 in dichloromethane, add a dichloromethane solution of 1-(4-fluorophenyl)piperazine and triethylamine, and carry out a nucleophilic substitution reaction to obtain the niprazine; The process route is as follows: 。 2. The preparation method according to claim 1, characterized in that, In step (1), the molar ratio of nicotinic acid, 3-amino-1-butanol, HATU and triethylamine is 1:1:1.20:

2.

3. The preparation method according to claim 1, characterized in that, In step (2), the molar ratio of compound 2, methanesulfonyl chloride and triethylamine is 1:1.05:1.

2.

4. The preparation method according to claim 1, characterized in that, In step (3), the molar ratio of compound 3, 1-(4-fluorophenyl)piperazine and triethylamine is 1:1.05:1.

2.

5. The preparation method according to claim 1, characterized in that, The organic solvent is dichloromethane.

6. The preparation method according to claim 1, characterized in that, The amide coupling reaction was carried out at a temperature of 20-25°C for 16 hours.

7. The preparation method according to claim 1, characterized in that, After the reaction in step (1) is completed, the reaction solution is washed with water and hydrochloric acid solution in sequence. The resulting organic phase is dried, filtered and concentrated to obtain crude compound 2, which is then purified by silica gel column chromatography to obtain compound 2. The silica gel column chromatography eluent is a mixed solution of methanol and dichloromethane.

8. The preparation method according to claim 1, characterized in that, The specific steps of step (2) are as follows: triethylamine is added to the dichloromethane solution of compound 2, and methanesulfonyl chloride is added dropwise under ice bath conditions. After the addition is completed, the temperature is raised to room temperature and the reaction is carried out for 2.5 h. After the reaction is completed, water is added to quench the reaction. The organic phase is washed, dried, filtered and concentrated to obtain the crude product of compound 3, which is then purified by silica gel column chromatography to obtain compound 3. The eluent for silica gel column chromatography is a mixed solution of ethyl acetate and cyclohexane.

9. The preparation method according to claim 1, characterized in that, Step (3) is as follows: Triethylamine is added to the dichloromethane solution of compound 3. Under ice bath conditions, a dichloromethane solution of 1-(4-fluorophenyl)piperazine is added dropwise. After the addition is completed, the temperature is raised to room temperature and refluxed for 4.5 h. After the reaction is completed, water is added to quench the reaction. The organic phase is washed, dried, filtered and concentrated to obtain crude niprazine. Niprazine is then purified by silica gel column chromatography. The eluent for silica gel column chromatography is a mixed solution of ethyl acetate and cyclohexane.